NN is a diversified industrial company that manufactures high precision bearing components, industrial plastic products, and precision metal components. The Company manufactures and sells precision steel balls and rollers and precision metal retainers for roller bearings. It also manufactures a range of components, assemblies, and instruments for the medical end market, electrical contacts, assemblies and precision stampings for the electrical control end market, the automotive end market, and various engineered materials for the aerospace and defense end market. In addition, the Company manufactures and sells precision plastic retainers and various specialized plastic products. Further, it offers precision-machined metal components and subassemblies for the consumer transportation, industrial technology, HVAC, fluid power, and diesel engine end markets.

Type
Public
HQ
Johnson City, US
Founded
1980
Size (employees)
4,730 (est)
Website
nninc.com
NN was founded in 1980 and is headquartered in Johnson City, US
Report incorrect company information

NN Office Locations

NN has offices in Kamienna Góra, Wuxi, Marnaz, Boituva and in 5 other locations
Johnson City, US (HQ)
207 Mockingbird Ln
Attleboro, US
110 Frank Mossberg Drive
Kentwood, US
4180 40th Street SE
Boituva, BR
Rodovia Boituva-Porto Feliz km 12, 1230
Foshan, CN
7 Xinyue Road, Bldg. 6 Shunde Industrial Park Wusha Daliang, Shunde District
Wuxi, CN
No. 17 Changjiang Road New District
Show all (9)
Report incorrect company information

NN Financials and Metrics

NN Financials

NN's revenue was reported to be $833.49 m in FY, 2016 which is a 24.9% increase from the previous period.
USD

Revenue (Q3, 2017)

148.2 m

Gross profit (Q3, 2017)

37.3 m

Gross profit margin (Q3, 2017), %

25.2%

Net income (Q3, 2017)

132.9 m

EBIT (Q3, 2017)

6.3 m

Market capitalization (23-Apr-2018)

605.1 m

Cash (30-Sep-2017)

347.4 m

EV

1.1 b
NN's current market capitalization is $605.1 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

373.2 m488.6 m667.3 m833.5 m

Revenue growth, %

31%37%25%

Cost of goods sold

526 m621 m

Gross profit

141.3 m212.5 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

93 m102.5 m106.7 m125.6 m163.7 m164.9 m154.8 m212.2 m214.3 m205 m226.3 m225.9 m148.2 m

Cost of goods sold

73 m80.3 m84.3 m100.4 m129.3 m128.7 m120.2 m159.8 m156.8 m152.5 m167 m166 m110.8 m

Gross profit

20 m22.2 m22.4 m25.2 m34.4 m36.1 m34.6 m52.5 m57.5 m52.4 m59.4 m59.8 m37.3 m

Gross profit Margin, %

22%22%21%20%21%22%22%25%27%26%26%26%25%
Annual
usdY, 2009Y, 2010Y, 2011Y, 2012Y, 2013Y, 2014Y, 2015FY, 2016

Cash

8.7 m5.6 m4.5 m19 m3 m37.3 m15.1 m14.4 m

Accounts Receivable

58.9 m97.5 m123 m139.5 m

Inventories

54.5 m91.5 m119.8 m114.9 m

Current Assets

125.7 m242.8 m280.2 m280.6 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

4.5 m4.5 m5.8 m26.9 m16.8 m21.4 m40.1 m15.1 m15.1 m14.8 m19.6 m19.2 m347.4 m

Accounts Receivable

117.2 m114.8 m108.1 m143.3 m147.1 m147.4 m159.6 m162.4 m108.2 m

Inventories

48.1 m57.4 m61.5 m86.9 m85.6 m87.9 m92.6 m120.1 m118.8 m118.8 m116.6 m123.7 m76.6 m

Current Assets

126.8 m146.4 m158 m246.7 m238 m240.7 m258.4 m295.6 m297.9 m295.5 m310.3 m327.6 m552.4 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

17.2 m8.2 m(7.4 m)7.9 m

Depreciation and Amortization

17 m22.1 m44.5 m62.5 m

Inventories

(7.2 m)(9.8 m)(1.8 m)4.4 m

Accounts Payable

2.6 m9.5 m(6.7 m)7.6 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017

Net Income

5.1 m5.2 m5.2 m(3.8 m)6 m7 m4.6 m(1.3 m)2 m4.1 m7.4 m132.9 m

Depreciation and Amortization

4.1 m3.9 m4.1 m5.9 m8.5 m8.6 m8.6 m17.3 m15.1 m14.7 m15.6 m

Inventories

87.9 m92.6 m120.1 m118.8 m118.8 m116.6 m76.6 m

Accounts Payable

63.6 m60.3 m70.3 m65.9 m69.7 m77.7 m48.3 m
USDY, 2017

EV/EBIT

167 x

Revenue/Employee

31.3 k

Debt/Equity

1.8 x

Debt/Assets

0.5 x

Financial Leverage

3.4 x
Show all financial metrics
Report incorrect company information

NN News and Updates

BRIEF-Beecken Petty O'Keefe & Co To Sell PMG Intermediate Holding Corp To NN Inc

* BEECKEN PETTY O'KEEFE & COMPANY ANNOUNCES DEFINITIVE AGREEMENT TO SELL PARAGON MEDICAL

Parcom Capital buys Viroclinics

Parcom Capital said Aug. 29 that it has acquired Viroclinics Biosciences. Financial terms weren’t announced. Viroclinics, of the Netherlands, tests new vaccines and drugs in the clinical trial stages prior to their market launch.
Report incorrect company information